Prior studies have highlighted the roles of TGF-β and SDF-1/CXCL12 in the differentiation of fibroblasts into CAFs and the promotion of a tumor-enhancing phenotype in breast cancer cells. This evidence concerns the gene CXCL12 and breast cancer.